Effects of general practice-based nurse-counselling on ambulatory blood pressure and antihypertensive drug prescription in patients at increased risk of cardiovascular disease

Journal of Human Hypertension

Volumn 17, Issue 10, 2003, Pages 689-695

  Woollard, J ^a,b   Burke, V ^a,b   Beilin, L J ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Ambulatory blood pressure; Antihypertensive drugs; Health promotion; Primary care

Indexed keywords

ANGIOTENSIN II ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INDAPAMIDE; METHYLDOPA; PRAZOSIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; DIET THERAPY; FEMALE; GENERAL PRACTICE; HEALTH PROGRAM; HEART RATE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; LIFESTYLE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NURSE PRACTITIONER; OUTCOMES RESEARCH; PATIENT CARE; PATIENT COMPLIANCE; PATIENT COUNSELING; PHYSICAL ACTIVITY; PRESCRIPTION; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; SYSTOLIC BLOOD PRESSURE; TELEPHONE; WEIGHT REDUCTION;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CARDIOVASCULAR DISEASES; COUNSELING; FAMILY PRACTICE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NURSING EVALUATION RESEARCH; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0142030970     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001593     Document Type: Article

References (19)

1. Beilin LJ, Puddey IB, Burke V. Lifestyle and hypertension. Am J Hypertens 1999; 12: 934-945.
2. Ebrahim S, Smith Davey G. Systematic review of randomised controlled trials of multiple risk factor interventions for preventing coronary heart disease. BMJ 1997; 314: 1666-1674.
3. Cupples ME, McKnight A. Randomised controlled trial of health promotion in general practice for patients at high cardiovascular risk. BMJ 1994; 309: 993-996.
4. Ebrahim S, Smith Davey G, Bennett R. Health promotion activity should be retargeted at secondary prevention. BMJ 2000; 320: 185.
5. Steptoe A et al. Behavioural counselling in general practice for the promotion of healthy behaviour among adults at increased risk of coronary heart disease: Randomised trial. BMJ 1999; 319: 943-948.
6. Prochaska JO, DiClemente CC, Norcross JC. In search of how people change. Am Psychol 1992; 47: 1102-1114.
7. Woollard J et al. A controlled trial of nurse counselling on lifestyle change for hypertensives treated in general practice: Preliminary results. Clin Exp Pharmacol Physiol 1995; 22: 466-468.
8. Woollard J et al. Effects of a general practice-based intervention on diet, body mass index and blood lipids in patients at cardiovascular risk. J Cardiovasc Risk 2003; 10: 31-40.
9. Wheeler C et al. Reproducibility of a meal-based food frequency questionnaire. The influence of format and time interval between questionnaires. Eur J Clin Nutr 1994; 48: 795-809.
10. Blair SN et al. Assessment of habitual physical activity by a seven day recall in a community survey and controlled experiments. Am J Epidemiol 1985; 122: 794-804.
11. Mori TA et al. Effects of varying fat, fish and fish oils on blood lipids in a randomized controlled trial in men at risk of heart disease. Am J Clin Nutr 1994; 59: 1060-1068.
12. Anonymous. WHO-International Society of Hypertension guidelines for the management of hypertension, guidelines subcommittee. J Hypertens 1999; 17: 151-183.
13. Aminoff UB, Kjellgren KI, The nurse - A resource in hypertension care. J Adv Nursing 2001; 35: 582-589.
14. Alderman MH, Madhavan S, Cohen H. Antihypertensive drug therapy: The effect of JNC criteria on prescribing patterns and patient status through the first year. Am J Hypertens 1996; 9: 413-418.
15. Flack JM, Novikov SV, Ferrarrio CM. Benefits of adherence to anti-hypertensive drug therapy. Eur Heart J 1996; 17(Suppl A): 16-20.
16. Feldman R et al. Adherence to pharmacologic management of hypertension. Can J Public Health 1998; 89: 116-118.
17. Caro JJ et al. Persistence with treatment for hypertension in actual practice. Can Med Assoc J 1999; 160: 31-37.
18. Cohen JS. Adverse drug effects, compliance, and initial doses of antihypertensive drugs recommended by the Joint National Committee vs the Physicians' Desk Reference. Arch Intern Med 2001; 161: 880-885.
19. Mar J, Rodriguez-Artalejo F. Which is more important for the efficiency of hypertension treatment: Hypertension stage, type of drug or therapeutic compliance? J Hypertens 2001; 19: 149-155.